Betel quids raise pharma concerns in Bangladesh
Chewing betel quids could lead Bangladeshi people to need pharma intervention

Bioanalytical

Betel quids raise pharma concerns in Bangladesh

08 Feb, 2011

Published over 15 years ago. See the latest and most current information on Bioanalytical.

Pharma firms operating in Bangladesh must contend with relatively high levels of poisons including arsenic and manganese in the groundwater supply, note researchers writing in BMC Public Health.

The team from Leicester's De Montfort University explain that excessive manganese exposure can cause negative health effects similar to those seen in Parkinson's Disease.

However, they have now looked into the possibility of exposure to the element through betel quid chewing, using inductively coupled plasma mass spectrometry to analyse urinary output.

A betel quid consists of chopped areca nut, calcium hydroxide, flavourings such as tobacco leaves and an outer layer of Piper betel leaves.

Some ten per cent of the world's population chew betel quids on a daily basis, the researchers add.

However, the negative impacts could leave those in Bangladesh requiring pharmaceutical assistance, as they exhibited a 210 per cent increase in manganese concentration in their urine.

BMC Public Health specialises in publishing research pertaining to the epidemiology of disease and its impact on populations in general.

Latest News

Explore Our Other Sites

Labmate Online
Single medium supports both 2D and 3D pluripotent stem cell culture and growth
Explore more Arrow
Envirotech Online
Meeting to explore the challenges of measuring ammonia across energy, healthcare and the environment
Explore more Arrow
Pollution Solutions Online
Vacuum technology enables efficient lithium-ion battery recycling with recovery rates of up to 95%
Explore more Arrow
Petro Online
The expanding role of high-temperature, high-shear viscometry in modern engine oil development
Explore more Arrow